Skip to main contentSkip to navigation
Sirius Investors

AEMD Stock: Aethlon Medical, Inc. Stock Price, Analysis & Insights

Get live aemd stock price $4.84, comprehensive Aethlon Medical, Inc. stock analysis, charts, news, and expert forecast. Real-time aemd stock data and investment insights.

4.84
14.87%Today
AEMDAethlon Medical, Inc. • NASDAQ Capital Market • Healthcare
Market Cap
12.57M
Volume
1.37M
52W High
84.80
52W Low
3.42

Loading chart...

Company Overview

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Company Information

CEO
James B. Frakes
Sector
Healthcare
Industry
Medical - Devices
Employees
14

Contact Information

Address
11555 Sorrento Valley Road
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 0.0)

Higher growth potential with elevated volatility (Beta: 1.63)

Business Model & Strategy

Aethlon Medical, Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO James B. Frakes, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

Aethlon Medical, Inc. competes in the Medical - Devices within the broader Healthcare. With 12.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Aethlon Medical, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Aethlon Medical, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Aethlon Medical, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Aethlon Medical, Inc.
  • Investors should consider how Aethlon Medical, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

12.57M

P/E Ratio

0.02

Beta

1.63

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 12.57M market capitalization
  • Trading Volume: 1.37M shares traded today
  • Price Range: 52-week range of $3.42 - $84.80
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:0.02
EPS:$209.20
Beta:1.63
Avg Volume:116.34K

Market Analysis for Aethlon Medical, Inc.

Aethlon Medical, Inc. (AEMD) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 12.57M, the company represents a significant player in its market. The stock is currently trading at $4.84 with a positivedaily change of 14.87%.

The company's 14 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 0.02, beta of 1.63, and 52-week price range from $3.42 to $84.80when evaluating investment opportunities.

Why Invest in Aethlon Medical, Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under James B. Frakes
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.